Market revenue in 2023 | USD 182.8 million |
Market revenue in 2030 | USD 285.6 million |
Growth rate | 6.6% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 87.96% in 2023. Horizon Databook has segmented the France implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Ministry of Solidarity and Health (Ministère de la Santé et de la Prévention), in France, around 40,000 to 50,000 individuals die annually due to SCA and lack of timely intervention. People in France have easy access to healthcare facilities and an effective healthcare system.
In addition, around 80,000 implants for cardiac care are performed each year in the country, with around 15% of all implants under ICDs. Furthermore, for every 350,000 pacemaker implants, around 60,000 ICDs are implanted in the region.
Moreover, the region launched ETAPES program in 2018, which addressed various financial troubles associated with the adoption of remote cardiac monitoring, augmenting patients’ cardiac care. The study results showed that 59.4% success was gained by using simple traction, 9.4% of patients required additional incision, and 28.1% of the patients required mechanical sheath to remove lead adhesions.
Horizon Databook provides a detailed overview of country-level data and insights on the France implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into France implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account